This is a human randomized trial, not an animal or cell study. In 40 older adults, 400 mg a day of coenzyme Q10 for 12 weeks pushed CoQ10 up in the bloodstream. It did not raise CoQ10 inside muscle tissue or the mitochondria that sit within it. That is the central finding of a new double-blind, placebo-controlled trial in GeroScience, and it should make anyone who buys CoQ10 as a mitochondrial booster pause.
The Study at a Glance
A team led by Malte Schmücker and Steen Larsen at the University of Copenhagen, with collaborators in Italy, Latvia and Poland, recruited 40 community-dwelling older adults with an average age of 74 ± 4 years. They were randomly assigned to 400 mg of oral CoQ10 daily or a placebo for 12 weeks. Neither participants nor researchers knew who got which.
The design is the kind longevity researchers rarely get. Muscle biopsies were taken before and after the intervention, so the team could look at the tissue where mitochondrial energy production matters for physical function. They also ran oral glucose tolerance tests and VO2max tests.
What They Measured
The researchers measured:
- Mitochondrial respiratory capacity, in both isolated mitochondria and permeabilized muscle fibers
- Mitochondrial H2O2 emission, a marker of oxidant production
- Mitochondrial content
- CoQ10 levels and redox status in plasma, muscle tissue and isolated muscle mitochondria
- Glucose homeostasis, via the oral glucose tolerance test
- VO2max, resting metabolic rate, cognitive function and body composition
This was a thorough attempt to test whether a popular supplement does what its marketing implies.
The Striking Result: Blood Up, Mitochondria Unchanged
Plasma CoQ10 rose significantly with supplementation, and the redox status (the balance between its oxidized and reduced forms) did not change. So the supplement was absorbed and entered circulation.
The next step is where the story stalls. The authors report no changes between groups or over time in muscle and isolated mitochondria for:
- Mitochondrial respiratory capacity
- H2O2 emission
- Mitochondrial content
- CoQ10 levels
Glucose homeostasis, VO2max and body composition were also unchanged. The abstract does not give effect sizes for these null results, so this article does not quote any.
The finding is a gap between plasma and tissue. A higher blood number is easy to produce and easy to sell, but it does not show that the molecule reached the place it is supposed to act.
Why This Matters for the Longevity Crowd
CoQ10 has an appealing story. It is part of the electron transport system that makes cellular energy, it works as an antioxidant, and the body's ability to make it may change with age. Supplementing therefore seems logical.
This trial challenges the last step of that logic, at least in this population. If the muscle mitochondria do not take up extra CoQ10 after three months at a fairly high dose, any downstream benefit through muscle mitochondrial function looks unlikely. In this group, none of the measured functional outcomes moved either.
Limitations and Fine Print
The authors describe their cohort as "robust older adults," and that qualifier matters.
- Small sample. With 40 participants, a modest effect could be missed. The trial shows no detectable change, which is not the same as proof of no effect.
- Healthy, robust participants. People with no deficiency may have little room to improve. The results may not apply to frail or ill people.
- Short duration. Twelve weeks may not be long enough to see tissue changes or longer-term outcomes.
- One dose. Only 400 mg/day was tested. Other doses, formulations or longer protocols were not.
- One tissue. The study looked at skeletal muscle. It says nothing about CoQ10 uptake in the heart, brain or other organs.
- Conflict of interest. Senior author S. Larsen discloses consulting for Pharma Nord, a supplement company. The other authors declare no conflicts, and the funders had no role in the study's design, analysis or publication. The disclosure is worth noting, particularly since the results were null rather than favorable to a supplement maker.
Who Might Still Benefit? (Not Tested Here)
This trial does not say CoQ10 is useless for everyone. Several groups are often discussed in connection with CoQ10, but none of them were studied in this trial:
- Statin users. Statins affect the pathway that also produces CoQ10, which is why people ask about it. This trial did not test statin users or muscle symptoms.
- People with a true CoQ10 deficiency. Participants here were robust, not deficient.
- People with heart failure. This is a major area of CoQ10 research, but these participants did not have heart failure.
These are open questions, not endorsements. Do not read this study as either supporting or ruling out CoQ10 in those settings.
Practical Takeaways
Dose: The trial used 400 mg daily for 12 weeks. That raised blood levels but did not change the muscle measures. Taking more is not a proven fix.
Timing: The trial summary gives no evidence about the best time of day. CoQ10 is fat-soluble, so supplement labels commonly suggest taking it with a meal containing fat. That is general guidance, not a finding from this study.
Who it is for: Based on this study, healthy older adults hoping to improve mitochondrial function, VO2max or glucose control have little evidence here to justify it. Anyone considering it for a specific condition should talk to a clinician.
Who should skip it or ask first: People on blood thinners such as warfarin should check with their doctor, as CoQ10 has been reported to interact with anticoagulants. The same applies to anyone on multiple medications, people with a chronic condition, or those who are pregnant or nursing.
Keep in mind: A blood test showing higher CoQ10 after supplementing tells you the capsule was absorbed. It does not tell you your mitochondria are working better.
The Bottom Line
In a well-designed double-blind trial with muscle biopsies, 400 mg/day of CoQ10 for 12 weeks raised plasma CoQ10 in 40 healthy older adults. It left muscle and mitochondrial CoQ10, mitochondrial function, glucose homeostasis, VO2max and body composition unchanged. The study is small and short and covers a healthy population, so it cannot close the case on CoQ10 for every group. It does show that a higher blood level should not be mistaken for a mitochondrial benefit.
